These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12396722)

  • 21. [Function, molecular structure and gene expression of interferons].
    Yoshida I; Azuma M
    Nihon Rinsho; 1992 Aug; 50(8):1845-53. PubMed ID: 1279237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta.
    Jaitin DA; Roisman LC; Jaks E; Gavutis M; Piehler J; Van der Heyden J; Uze G; Schreiber G
    Mol Cell Biol; 2006 Mar; 26(5):1888-97. PubMed ID: 16479007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Interferon signaling pathways].
    Gongora C; Mechti N
    Bull Cancer; 1999 Nov; 86(11):911-9. PubMed ID: 10586107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interferon receptors.
    Pestka S
    Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-18-S9-40. PubMed ID: 9208871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon receptor expression regulates the antiproliferative effects of interferons on cancer cells and solid tumors.
    Wagner TC; Velichko S; Chesney SK; Biroc S; Harde D; Vogel D; Croze E
    Int J Cancer; 2004 Aug; 111(1):32-42. PubMed ID: 15185340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Jak-STAT pathway stimulated by interferon alpha or interferon beta.
    Horvath CM
    Sci STKE; 2004 Nov; 2004(260):tr10. PubMed ID: 15561979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type I interferons: expression and signalization.
    Doly J; Civas A; Navarro S; Uze G
    Cell Mol Life Sci; 1998 Oct; 54(10):1109-21. PubMed ID: 9817990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of the type I IFN induction: a current view.
    Honda K; Yanai H; Takaoka A; Taniguchi T
    Int Immunol; 2005 Nov; 17(11):1367-78. PubMed ID: 16214811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of C1-inhibitor synthesis by interferons and other agents.
    Lappin D; Whaley K
    Behring Inst Mitt; 1989 Jul; (84):180-92. PubMed ID: 2478116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis.
    Kato A; Ohnishi Y; Kohase M; Saito S; Tashiro M; Nagai Y
    J Virol; 2001 Apr; 75(8):3802-10. PubMed ID: 11264369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type I interferons and autoimmunity: lessons from the clinic and from IRF-2-deficient mice.
    Taki S
    Cytokine Growth Factor Rev; 2002; 13(4-5):379-91. PubMed ID: 12220551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early alpha/beta interferon production by myeloid dendritic cells in response to UV-inactivated virus requires viral entry and interferon regulatory factor 3 but not MyD88.
    Hidmark AS; McInerney GM; Nordström EK; Douagi I; Werner KM; Liljeström P; Karlsson Hedestam GB
    J Virol; 2005 Aug; 79(16):10376-85. PubMed ID: 16051830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional role of type I and type II interferons in antiviral defense.
    Müller U; Steinhoff U; Reis LF; Hemmi S; Pavlovic J; Zinkernagel RM; Aguet M
    Science; 1994 Jun; 264(5167):1918-21. PubMed ID: 8009221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A peptide mimetic of human interferon (IFN)-beta.
    Sato A; Sone S
    Biochem J; 2003 Apr; 371(Pt 2):603-8. PubMed ID: 12542398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New aspects of IFN-alpha/beta signalling in immunity, oncogenesis and bone metabolism.
    Takaoka A; Taniguchi T
    Cancer Sci; 2003 May; 94(5):405-11. PubMed ID: 12824884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential Inhibition of HIV Replication by the 12 Interferon Alpha Subtypes.
    Tauzin A; Espinosa Ortiz A; Blake O; Soundaramourty C; Joly-Beauparlant C; Nicolas A; Droit A; Dutrieux J; Estaquier J; Mammano F
    J Virol; 2021 Jul; 95(15):e0231120. PubMed ID: 33980591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The soluble murine type I interferon receptor Ifnar-2 is present in serum, is independently regulated, and has both agonistic and antagonistic properties.
    Hardy MP; Owczarek CM; Trajanovska S; Liu X; Kola I; Hertzog PJ
    Blood; 2001 Jan; 97(2):473-82. PubMed ID: 11154225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A type I interferon signaling factor, ISF21, encoded on chromosome 21 is distinct from receptor components and their down-regulation and Is necessary for transcriptional activation of interferon-regulated genes.
    Holland KA; Owczarek CM; Hwang SY; Tymms MJ; Constantinescu SN; Pfeffer LM; Kola I; Hertzog PJ
    J Biol Chem; 1997 Aug; 272(34):21045-51. PubMed ID: 9261106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of Ligand Specificity and Functional Plasticity in Type I Interferon Signaling.
    Kirby D; Parmar B; Fathi S; Marwah S; Nayak CR; Cherepanov V; MacParland S; Feld JJ; Altan-Bonnet G; Zilman A
    Front Immunol; 2021; 12():748423. PubMed ID: 34691060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of interferon-dependent mRNA translation of target genes.
    Kroczynska B; Mehrotra S; Arslan AD; Kaur S; Platanias LC
    J Interferon Cytokine Res; 2014 Apr; 34(4):289-96. PubMed ID: 24559173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.